C5AR1 and Sepsis: In fact, C5aR1 has been proposed as a therapeutic target to treat other inflammatory conditions, including inflammatory bowel disease (58), neurodegenerative diseases (59), ischemia-reperfusion injury (60), and general sepsis (61).